Vaccine Development: Strategic Approach & Response During Pandemics
Source: Thermo Fisher Scientific
Over the past decade, outbreaks of H1N1 influenza, Sars-Cov, Ebola, and MERS have sparked ongoing conversations about strategic approaches and responses to pandemics and epidemics. Now with the spread of SARS-CoV-2 intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring these life-saving drugs to market faster without impacting product quality, safety, or efficacy.
Watch this on-demand webinar to learn about:
- Bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy
- Impacts and comparisons of classic platforms vs new-generation platforms
- Establishing a new and proactive approach to managing the unpredictable demand of life-saving products
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more